33 results
8-K
EX-99.1
INBX
Inhibrx Biosciences, Inc.
24 May 24
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
4:08pm
of people globally, while putting sustainability and social responsibility at the center of its ambitions.
Cautionary Statement Regarding Forward
8-K
EX-99.1
INBX
Inhibrx Biosciences, Inc.
8 May 24
Other Events
4:42pm
globally, while putting sustainability and social responsibility at the center of its ambitions.
Cautionary Statement Regarding Forward-Looking
DEFM14A
INBX
Inhibrx Biosciences, Inc.
26 Apr 24
Proxy related to merger
4:06pm
identification number, which for an individual is ordinarily his or her social security number;
the holder furnishes an incorrect taxpayer identification … Copyrights, registered Design Rights, Design Rights registration applications, social media handles and internet domain names within the scope of the 101
DEFA14A
INBX
Inhibrx Biosciences, Inc.
23 Jan 24
Additional proxy soliciting materials
6:38am
, Design Rights registration applications, social media handles and internet domain names within the scope of the 101 Business (i) that are owned … seq.) and XIX (42 U.S.C. § 1396 et seq.) of the Social Security Act and the regulations promulgated thereunder; (d) the Medicare Prescription Drug
8-K
EX-99.1
ukdauv yjq1m
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
8-K
EX-2.1
6i3a98ve
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
8-K
EX-2.2
cdw10eiii7gii1frqqz
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
S-3ASR
EX-1.2
bz0lrl45 9qg1nsu
3 Sep 21
Automatic shelf registration
4:22pm
10-K
vkj1x1zdd o60
12 Mar 21
Annual report
8:46am
10-Q
96i jb3hhl60
13 Nov 20
Quarterly report
4:09pm